Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Progress Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Progress Update

Seres Therapeutics (MCRB) Misses Q1 EPS by 2c

May 16, 2016 7:12 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.50), $0.02 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $2.71 million versus the consensus estimate of $1.25 million.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More